Intestinal Inhibition of the Na + /H + Exchanger 3 Prevents Cardiorenal Damage in Rats and Inhibits Na + Uptake in Humans-Reference-Cited by-同舟云学术

Intestinal Inhibition of the Na + /H + Exchanger 3 Prevents Cardiorenal Damage in Rats and Inhibits Na + Uptake in Humans

Published:2014-03-12 Issue:227 Volume:6 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Spencer Andrew G.¹,Labonte Eric D.¹,Rosenbaum David P.¹,Plato Craig F.²,Carreras Christopher W.¹,Leadbetter Michael R.¹,Kozuka Kenji¹,Kohler Jill¹,Koo-McCoy Samantha¹,He Limin¹,Bell Noah¹,Tabora Jocelyn¹,Joly Kristin M.²,Navre Marc¹,Jacobs Jeffrey W.¹,Charmot Dominique¹

Affiliation:

1. Ardelyx Inc., Fremont, CA 94555, USA.

2. Plato BioPharma Inc., Westminster, CO 80021, USA.

Abstract

An inhibitor of intestinal NHE3 reduces absorption of dietary sodium in rats and humans and prevents salt-induced cardiorenal injury in nephrectomized rats.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference66 articles.

1. MOLECULAR PHYSIOLOGY OF INTESTINAL N+/H+ EXCHANGE

2. THE EPITHELIAL BRUSH BORDER Na/HEXCHANGER NHE3 ASSOCIATES WITH THE ACTIN CYTOSKELETON BY BINDING TO EZRIN DIRECTLY AND VIA PDZ DOMAIN-CONTAINING Na/HEXCHANGER REGULATORY FACTOR (NHERF) PROTEINS

3. Biology of Human Sodium Glucose Transporters

4. Molecular biology of Na+ absorption.;Barbry P.;Am. J. Physiol.,1997

5. Subcloning, localization, and expression of the rat intestinal sodium-hydrogen exchanger isoform 8

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Landscape of Therapeutics for the Management of Hypertension - A Review;Current Drug Delivery;2024-06

2. Heart Failure: a Punch from the Gut;Current Heart Failure Reports;2024-02-01

3. Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract—Case Study: Tenapanor;Pharmaceutics;2023-12-04

4. A pharmacokinetic evaluation of tenapanor for the treatment of irritable bowel syndrome with constipation: an update of the literature;Expert Opinion on Drug Metabolism & Toxicology;2023-12-02

5. Randomized Study of Tenapanor Added to Phosphate Binders for Patients With Refractory Hyperphosphatemia;Kidney International Reports;2023-11